» Articles » PMID: 37962464

Recurrent Phases of Strict Protein Limitation Inhibit Tumor Growth and Restore Lifespan in A Drosophila Intestinal Cancer Model

Overview
Journal Aging Dis
Specialty Geriatrics
Date 2023 Nov 14
PMID 37962464
Authors
Affiliations
Soon will be listed here.
Abstract

Diets that restrict caloric or protein intake offer a variety of benefits, including decreasing the incidence of cancer. However, whether such diets pose a substantial therapeutic benefit as auxiliary cancer treatments remains unclear. We determined the effects of severe protein depletion on tumorigenesis in a Drosophila melanogaster intestinal tumor model, using a human RAF gain-of-function allele. Severe and continuous protein restriction significantly reduced tumor growth but resulted in premature death. Therefore, we developed a diet in which short periods of severe protein restriction alternated cyclically with periods of complete feeding. This nutritional regime reduced tumor mass, restored gut functionality, and rescued the lifespan of oncogene-expressing flies to the levels observed in healthy flies on a continuous, fully nutritious diet. Furthermore, this diet reduced the chemotherapy-induced stem cell activity associated with tumor recurrence. Transcriptome analysis revealed long-lasting changes in the expression of key genes involved in multiple major developmental signaling pathways. Overall, the data suggest that recurrent severe protein depletion effectively mimics the health benefits of continuous protein restriction, without undesired nutritional shortcomings. This provides seminal insights into the mechanisms of the memory effect required to maintain the positive effects of protein restriction throughout the phases of a full diet. Finally, the repetitive form of strict protein restriction is an ideal strategy for adjuvant cancer therapy that is useful in many tumor contexts.

Citing Articles

Metabolic Adaptations in Cancer and the Host Using Models and Advanced Tools.

Saez-Carrion E, Aguilar-Aragon M, Garcia-Lopez L, Dominguez M, Uribe M Cells. 2024; 13(23).

PMID: 39682725 PMC: 11640731. DOI: 10.3390/cells13231977.


Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review.

Golonko A, Pienkowski T, Swislocka R, Orzechowska S, Marszalek K, Szczerbinski L Cell Death Dis. 2024; 15(4):254.

PMID: 38594256 PMC: 11004013. DOI: 10.1038/s41419-024-06641-6.

References
1.
Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H . Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease. Digestion. 2016; 93(1):59-65. DOI: 10.1159/000441768. View

2.
Papadimitriou N, Dimou N, Tsilidis K, Banbury B, Martin R, Lewis S . Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat Commun. 2020; 11(1):597. PMC: 6992637. DOI: 10.1038/s41467-020-14389-8. View

3.
David L, Maurice C, Carmody R, Gootenberg D, Button J, Wolfe B . Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2013; 505(7484):559-63. PMC: 3957428. DOI: 10.1038/nature12820. View

4.
de Groot S, Lugtenberg R, Cohen D, Welters M, Ehsan I, Vreeswijk M . Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat Commun. 2020; 11(1):3083. PMC: 7311547. DOI: 10.1038/s41467-020-16138-3. View

5.
Nencioni A, Caffa I, Cortellino S, Longo V . Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer. 2018; 18(11):707-719. PMC: 6938162. DOI: 10.1038/s41568-018-0061-0. View